From Inspiration to Recognition: ASCO Awards FASCO Title to Gevorg Tamamyan
Gevorg Tamamyan, Co-founder and Editor in Chief of OncoDaily, posted on LinkedIn:
”It is a great honor to be named a Fellow of the American Society of Clinical Oncology (FASCO) – a recognition bestowed upon ASCO members who have shown extraordinary dedication through their voluntary efforts to benefit the Society, the specialty of oncology, and, most importantly, the patients we serve.
Years ago, when I first set foot at ASCO’s Annual Meeting – when all of Chicago was alive with the movement of nearly fifty thousand oncologists and members from around the world – I remember watching, in awe, as the world’s leading experts, whose names I had only read in books, were called to the stage to receive the title of FASCO. I could never have imagined that one day…
What can I say – I am deeply grateful to everyone who, in one way or another, directly or indirectly, has helped make this day possible.
It is, indeed, a great honor – and an even greater responsibility.”

Keep up with Hemostasis Today.
-
Feb 16, 2026, 15:44Lakmali Silva: Silva Lab Showcases Research at the Gordon Research Conference on Plasminogen and Extracellular Proteolysis
-
Feb 16, 2026, 15:36Heghine Khachatryan: Strengthening Maternal Resilience Against Postpartum Hemorrhage
-
Feb 16, 2026, 15:34Sevak Mirabyan: Advancing Cancer Care Through Knowledge, Collaboration, and Early Diagnosis in Armenia
-
Feb 16, 2026, 15:29Chokri Ben Lamine: Key Clinical Insights of Drug Induced Thrombocytopenia
-
Feb 16, 2026, 15:28Ney Carter Borges: Coronary Intravascular Lithotripsy – Clinical Performance and Safety
-
Feb 16, 2026, 15:24Flora Peyvandi: Highlighting Overdose, Homicide, and Suicide as Causes of Maternal Death in the US
-
Feb 16, 2026, 14:53Wafaa Abougabal: Differential Diagnosis of Acute Neurologic Deficits and Stroke in PICU
-
Feb 16, 2026, 14:49Nayab Ahmed: Synthesis of ATP and Its Significance in Storage of Blood
-
Feb 16, 2026, 14:44Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES